By Palin Communications
March 2026
1 min read

Around 90% of drugs entering clinical trials fail. What if we could dramatically reduce that risk before a molecule ever reaches a lab?

A hologram demonstrating the computerised proteins generated by OmnigeniQ's Deterministic Intelligence Platform

That question sits at the heart of OmnigeniQ, an Australian, female-founded biotech whose origins lie not in pharma, but in space. The company’s Deterministic Intelligence platform grew out of NASA-linked research that was looking into insulin production in non-gravity environments and where understanding how proteins behave under physical constraints was mission-critical. 

Those same physics-based principles now underpin OmnigeniQ’s approach to drug discovery, enabling proteins to be computed in their true, dynamic state rather than inferred from predicted or static data. 

Palin Communications supported a profile-raising earned media program securing coverage across ABC, Forbes Australia, PharmaVoice, Drug Target Review, BioWorld and Pulse.IT. The campaign exceeded awareness KPIs and positioned OmnigeniQ’s all-female team as credible voices disrupting the future of drug development. 

By Anastasiia Nazarenko
12.11.2026
9 min read
Preparing to announce new research or clinical trial results? See how a specialist health PR agency can translate complex data, coordinate approvals and prepare communications before the embargo lifts.
By Palin Communications
09.11.2026
1 min read
Palin Communications has reinforced its position as the leading Australian PR agency in the health sector by once again being named as the Health Industry Hub PR and Advocacy Agency of Team of the Year.

Latest from LinkedIn

Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity
Creating Clarity in Complexity

Interested in working with the best?

We’re always happy to talk through what might be possible for you, from a health PR brief to what a great campaign might look like.